MDM2 is an E3-ubiquitin ligase which binds p53 to ubiquitinate and target it for degradation through ubiquitin/proteasome pathway [112], and is overexpressed in 58% of MM samples which has been frequently associated with chemoresistance [113, 114]. The gene discussed is TP53; the disease is Miyoshi myopathy.